U.S. Radiation Oncology Market Size & Outlook, 2020-2028
U.S. radiation oncology market, 2017-2028 (US$M)
Related Markets
U.S. radiation oncology market highlights
- The U.S. radiation oncology market generated a revenue of USD 3,101.8 million in 2020 and is expected to reach USD 5,455.2 million by 2028.
- The U.S. market is expected to grow at a CAGR of 7.3% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 3,101.8 million |
| Market revenue in 2028 | USD 5,455.2 million |
| Growth rate | 7.3% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, U.S. accounted for 40.9% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 641.7 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 65.8% in 2020. Horizon Databook has segmented the U.S. radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
As per the American Cancer Society, in the U.S., 1,762,450 new cancer cases are estimated to be diagnosed and 606,880 people are expected to die from cancer in 2019. Cancer is the second most common cause of death in the U.S. Rising collaborations among organizations to improve the quality of care for people living with cancer are among the major factors driving the market growth in this country.
In January 2018, ASTRO collaborated with American Society of Clinical Oncology (ASCO) to launch a new registry Qualified Clinical Data Registry (QCDR). This registry tracks the quality of medical care provided to patients undergoing cancer treatment and also makes it easier for radiation and medical oncologists to report quality-related performance metrics needed by the Federal government.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. radiation oncology market size, by type, 2017-2028 (US$M)
U.S. Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
